9454525

Source:http://linkedlifedata.com/resource/pubmed/id/9454525

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0011860, umls-concept:C0034656, umls-concept:C0245514, umls-concept:C0311400, umls-concept:C1280500
pubmed:issue	3
pubmed:dateCreated	1998-2-5
pubmed:abstractText	Troglitazone is a new insulin-sensitizing agent used to treat type 2 diabetes mellitus. The mechanism by which troglitazone exerts its effect on systemic glucose metabolism is unknown.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/MO1-RR00827, http://linkedlifedata.com/resource/pubmed/grant/R01-DK 33649, http://linkedlifedata.com/resource/pubmed/grant/R01-DK 49230
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/9454525-10049210
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide, http://linkedlifedata.com/resource/pubmed/chemical/Chromans, http://linkedlifedata.com/resource/pubmed/chemical/Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Placebos, http://linkedlifedata.com/resource/pubmed/chemical/Thiazoles, http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones, http://linkedlifedata.com/resource/pubmed/chemical/troglitazone
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0003-4819
pubmed:author	pubmed-author:BuchananT ATA, pubmed-author:BurantC FCF, pubmed-author:ClineGG, pubmed-author:GumbinerBB, pubmed-author:HsuehW AWA, pubmed-author:InzucchiSS, pubmed-author:KellerMM, pubmed-author:MaggsD GDG, pubmed-author:NolanJJ, pubmed-author:OlefskyJ MJM, pubmed-author:PolonskyK SKS, pubmed-author:ShulmanG IGI, pubmed-author:SilverDD, pubmed-author:ValiquettT RTR
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	128
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	176-85
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:9454525-Adult, pubmed-meshheading:9454525-Aged, pubmed-meshheading:9454525-Analysis of Variance, pubmed-meshheading:9454525-Blood Glucose, pubmed-meshheading:9454525-C-Peptide, pubmed-meshheading:9454525-Chromans, pubmed-meshheading:9454525-Diabetes Mellitus, Type 2, pubmed-meshheading:9454525-Double-Blind Method, pubmed-meshheading:9454525-Female, pubmed-meshheading:9454525-Glucose, pubmed-meshheading:9454525-Glucose Clamp Technique, pubmed-meshheading:9454525-Humans, pubmed-meshheading:9454525-Hypoglycemic Agents, pubmed-meshheading:9454525-Insulin, pubmed-meshheading:9454525-Insulin Resistance, pubmed-meshheading:9454525-Liver, pubmed-meshheading:9454525-Male, pubmed-meshheading:9454525-Middle Aged, pubmed-meshheading:9454525-Placebos, pubmed-meshheading:9454525-Regression Analysis, pubmed-meshheading:9454525-Thiazoles, pubmed-meshheading:9454525-Thiazolidinediones
pubmed:year	1998
pubmed:articleTitle	Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
pubmed:affiliation	Yale University School of Medicine, New Haven, CT 06520-8020, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study